Dematté, B.E.; Vasques, J.F.; da Silva-Junior, A.J.; Franco, L.S.; Maia, R.d.C.; Pinheiro, P.d.S.M.; Mendez-Otero, R.; Montagnoli, T.L.; Zapata-Sudo, G.
Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor. Pharmaceuticals 2026, 19, 907.
https://doi.org/10.3390/ph19060907
AMA Style
Dematté BE, Vasques JF, da Silva-Junior AJ, Franco LS, Maia RdC, Pinheiro PdSM, Mendez-Otero R, Montagnoli TL, Zapata-Sudo G.
Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor. Pharmaceuticals. 2026; 19(6):907.
https://doi.org/10.3390/ph19060907
Chicago/Turabian Style
Dematté, Bruno Eduardo, Juliana Ferreira Vasques, Almir Jordão da Silva-Junior, Lucas Silva Franco, Rodolfo do Couto Maia, Pedro de Sena Murteira Pinheiro, Rosalia Mendez-Otero, Tadeu Lima Montagnoli, and Gisele Zapata-Sudo.
2026. "Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor" Pharmaceuticals 19, no. 6: 907.
https://doi.org/10.3390/ph19060907
APA Style
Dematté, B. E., Vasques, J. F., da Silva-Junior, A. J., Franco, L. S., Maia, R. d. C., Pinheiro, P. d. S. M., Mendez-Otero, R., Montagnoli, T. L., & Zapata-Sudo, G.
(2026). Multitarget Strategy for Treatment of Pulmonary Arterial Hypertension: Combination of Mesenchymal Cells with Novel PDE-4 Inhibitor. Pharmaceuticals, 19(6), 907.
https://doi.org/10.3390/ph19060907
